Theratechnologies Beta
Что обозначает Beta в Theratechnologies?
Beta Theratechnologies, Inc. является 1.38
Какое определение для Beta?
БЕТА показывает, если акция является более или менее волатильной, чем рынок в целом. Бета меньше 1 указывает на то, что акции менее волатильные, чем рынок, а бета больше 1 указывает на то, что акции более волатильные. Волатильность измеряется как колебание цены вокруг среднего значения.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta компаний в Health Care сектор на TSX по сравнению с Theratechnologies
Что делает Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Компании с beta похож на Theratechnologies
- AXA SA имеет Beta из 1.38
- AXA SA имеет Beta из 1.38
- Freshii имеет Beta из 1.38
- Zai Lab имеет Beta из 1.38
- IFCI имеет Beta из 1.38
- IFCI имеет Beta из 1.38
- Theratechnologies имеет Beta из 1.38
- Beowulf Mining plc имеет Beta из 1.38
- Systemair AB (publ) имеет Beta из 1.38
- engage:BDR имеет Beta из 1.38
- Adtran имеет Beta из 1.38
- Abercrombie & Fitch Co имеет Beta из 1.38
- TruFin plc имеет Beta из 1.38